About Yoh-Chie Lu
Form D filings for Nuvaira in 2022 list Yoh-Chie Lu as director.
Form D filings also name Yoh-Chie Lu as a director at Earlens.
Yoh-Chie Lu first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Yoh-Chie Lu in the role, so the role may have started earlier or lasted longer.
Nuvaira, Inc.
Director
2022 · Minneapolis, MN
Develops a lung treatment device for people with chronic obstructive pulmonary disease.
Key Colleagues at Startups
The people Yoh-Chie Lu works with at each company, as listed on that company's latest Form D.
Nuvaira, Inc. · Form D/A, Jan 19, 2022
JR
Jonathan Root
Director
GR
Gary Rieschel
Director
Dennis Wahr
President & CEO, director
RH
Robert O'Holla
Director
TH
Tim Herbert
Director
HP
Henry Plain
Director
MC
Michael Carusi
Director
Earlens Corp · Form D, May 24, 2018
PL
Phil Lyons
Executive officer
JB
Judy Brimacombe
Executive officer
WF
William Facteau
President and CEO, director
TP
Thomas Prescott
Director
AT
Art Taylor
Director
MB
Mark Bishop
Executive officer
FT
Frank Torti
Director
GK
Greg Koskowich
Executive officer
RC
Robert Croce
Director
BS
Bernard Shay
Executive officer
SE
Steven Elms
Director
HJ
Henry Plain, Jr.
Director
RD
Rodney Perkins, M.D.
Director
JJ
Jeff Jones
Executive officer